Light-Activated gel shows promise for psoriasis in early trial
Disease control
Completed
This study tested a gel called SGX302 (synthetic hypericin) combined with visible light to treat mild-to-moderate psoriasis. 15 adults with plaque psoriasis applied the gel to their skin and received light therapy over 18 weeks. The goal was to see if the treatment could clear or…
Phase: PHASE2 • Sponsor: Soligenix • Aim: Disease control
Last updated May 17, 2026 03:53 UTC